Results 161 to 170 of about 46,577 (260)

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 [PDF]

, 2020
Enrique Fuentes‐Mattei, Recep Bayraktar, Taghi Manshouri, Andréia Maria da Silva, Cristina Ivan, Diana Gulei, Linda Fabris, Nayra Soares do Amaral, Pilar Mur, Cristina Pérez, Elizabeth Torres-Claudio, Mihnea P. Dragomir, Adriana Badillo-Perez, Erik Knutsen, Pranav Narayanan, Leonard S. Golfman, Masayoshi Shimizu, Xinna Zhang, Wanke Zhao, Wan‐Ting Ho, Marcos R. Estecio, Geoffrey Bartholomeusz, Ciprian Tomuleasa, Ioana Berindan‐Neagoe, Patrick A. Zweidler‐McKay, Zeev Estrov, Zhizhuang Joe Zhao, Srđan Verstovšek, George A. Calin, Roxana S. Redis   +29 more
openalex   +1 more source

Supplemental Figure 3 from Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations

Malathi Kandarpa, Dan R. Robinson, Yi‐Mi Wu, Tingting Qin, Kristen Pettit, Qing Li, Gary D. Luker, Maureen A. Sartor, Arul M. Chinnaiyan, Moshe Talpaz   +9 more
openalex   +1 more source

PF658 THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IS A CHEAP SURROGATE OF EXPANSION OF MYELOID‐DERIVED SUPPRESSOR CELLS IN MYELOFIBROSIS BEFORE AND AFTER TREATMENT WITH RUXOLITINIB: A SINGLE‐CENTER EXPERIENCE

, 2019
Antonio Romano, Nunziatina Laura Parrinello, Cesarina Giallongo, Fabrizio Puglisi, Daniela Cambria, Giuseppina Camiolo, Daniele Tibullo, E. Lambusta, Francesco Di Raimondo, Giuseppe A. Palumbo   +9 more
openalex   +1 more source

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial. [PDF]

Hematol Oncol
Melo Campos P, Pagnano KBB, Niemann FS, Mancuso RI, Della Via FI, Congrains A, Coelho-Silva JL, Tinoco ÂC, Assis-Mendonça GR, Freitas LLL, Traina F, Saad STO.   +11 more
europepmc   +1 more source

Myelofibrosis [PDF]

Proceedings of the Royal Society of Medicine, 1968
J. S. Malpas, Ronald Bodley Scott
openaire   +1 more source

VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia

eJHaem, 2023
Giovanni Barosi, Paolo Catarsi, Rita Campanelli, Margherita Massa, Adriana Carolei, Carlotta Abbà, Annalisa deSilvestri, Robert Peter Gale, Vittorio Rosti   +8 more
doaj   +1 more source

Concurrent Presentation of Pure Red Cell Aplasia and Myeloproliferative Neoplasm, Unclassifiable With JAK2 and MPL Mutations. [PDF]

Case Rep Hematol
Li Q, Tan L, Wang X, Fan Q.
europepmc   +1 more source

Prognostic utility of macrophage polarization (CD68/CD163 ratio) in Egyptian JAK2 positive myeloproliferative neoplasm patients: a single center study. [PDF]

Diagn Pathol
Mahgoub SMA, Yehia MSM, Arafat AMA.
europepmc   +1 more source

An exceptional case of myelodysplastic syndrome with myelofibrosis following combination chemotherapy for squamous cell lung cancer.

, 2013
Yihao Wang, Rong Fu, Zonghong Shao
openalex   +2 more sources

Predictors of Symptom Scores in Myeloproliferative Neoplasms: A Real-World Retrospective Cohort Study. [PDF]

Cancer Med
Khan MA, Naqvi SAA, Camoriano JK, Arana Yi CY, Andres JT, Blocher JL, Kosiorek HE, Riaz IB, Palmer JM.   +8 more
europepmc   +1 more source